DERMATA THERAPEUTICS, INC. Current Assets
DERMATA THERAPEUTICS, INC. (DRMA) had Current Assets of $5.16 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-11
- 2026-06-30: Assets, Current $5.16M.
- 2025-12-31: Assets, Current $7.86M.
- 2021-12-31: Assets, Current $11.62M.
- 2021-09-30: Assets, Current $13.69M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $5.16M 10-Q · filed 2026-08-11 |
| 2025-12-31 | $7.86M 10-Q · filed 2026-08-11 |
| 2021-12-31 | $11.62M 10-K · filed 2022-03-28 |
| 2021-09-30 | $13.69M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $1.14M 10-Q · filed 2021-09-27 |
| 2020-12-31 | $605.45K 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |